Skip to main content
logo
TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.6910
-0.0200 (-2.81%)
At close: Jul 24, 2026, 4:00 PM EDT
0.7000
+0.0090 (1.30%)
After-hours: Jul 24, 2026, 4:10 PM EDT

TELA Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
80.8180.2869.358.4541.4229.46
Revenue Growth
13.48%15.84%18.56%41.13%40.58%61.77%
Gross Profit
54.3554.3446.4940.1127.0418.81
Operating Income
-33.81-33.76-34.12-44.08-39.01-29.45
Net Income
-39.84-38.83-37.84-46.66-44.3-33.28
Earnings Per Share
-0.79-0.83-1.33-2.04-2.72-2.30
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
39.5450.8552.6746.7342.0243.93
Total Debt
55.8755.6541.1240.5239.9231.49
Net Cash (Debt)
-16.33-4.8111.556.212.112.44
Net Cash Growth
--85.81%195.48%-83.09%-71.45%
Net Cash Per Share
-0.33-0.100.400.270.130.86

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-29.66-28.22-41.6-40.86-40.75-30.43
Capital Expenditures
-0.54-0.45-0.99-0.61-0.87-0.63
Free Cash Flow
-30.2-28.67-42.58-41.47-41.62-31.06
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
67.25%67.69%67.08%68.62%65.30%63.85%
Operating Margin
-41.84%-42.05%-49.23%-75.40%-94.18%-99.96%
Pretax Margin
-49.00%-48.09%-54.81%-79.83%-106.95%-112.17%
Profit Margin
-49.30%-48.37%-54.60%-79.83%-106.95%-112.94%
FCF Margin
-37.37%-35.71%-61.45%-70.94%-100.49%-105.42%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.380.651.722.775.326.31